Sociedad Española de Oncología Médica (SEOM). Las cifras del cáncer en España 2022; 2022.
Barnes BB, Steindorf K, Hein R, Flesch-Janys D, Chang-Claude J. Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors. Cancer Epidemiol 2011;35(4):345-52.
European Cancer Information System (ECIS). European Union; 2020. Disponible en: https://ecis.jrc.ec.europa.eu 4. IARC Handbooks of cancer prevention. Breast Cancer Screening 2016;15.
Pike MC, Pearce CL, Wu AH. Prevention of cancers of the breast, endometrium and ovary. Oncogene 2004;23(38):6379-91.
Brinton L, Gaudet M, Gierach G. Breast cancer. Cancer Epidemiology and Prevention. Schottenfeld and Fraumeni. 4th edition. New York, NY: Oxford University Press; 2018. p. 861-88.
Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358(9291):1389-99.
Sociedad Española de Oncología Médica (SEOM). Manual SEOM de prevención y diagnóstico precoz del cáncer; 2017.
Shiyanbola OO, Arao RF, Miglioretti DL, et al. Emergin trends in family history of breast cancer and associated risk. Cancer Epidemiol Biomark Prev 2017;26(12):1753-60.
Kharazmi E, Chen T, Narod S, Sundquist K, Hemminki K. Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study. Breast Cancer Res Treat 2014;144(1):185-92.
Tung N, Lin UN, Kidd J, et al. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 2016;34(13):1460-8.
Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian and contralateral breast cancer for BRCA1 y BRCA2 mutation carriers. JAMA 2017;317(23):2402-16.
Cobain EF, Milliron KJ, Merajver SD. Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. Semin Oncol 2016;43(5):528-35.
Shiovitz S, Korde LA. Genetics of breast cancer: A topic in evolution. Ann Oncol 2015;26(7):1291-99.
Ferreira MA, Gamazon ER, Al-Ejeh F, et al. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nat Commun 2019;10(1):1741.
Giannakeas V, Lim DW, Narod SA. The risk of contralateral breast cancer: a SEER-based analysis. Br J Cancer 2021;125(4):601-10.
Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast-risk assessment and management options. N Engl J Med 2015;372(1):78-89.
Dyrstad SW, Yan Y, Fowler AM, Colditz GA. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res Treat 2015;149(3):569-75.
Morrow M, Schnitt SJ, Norton L. Current management of lesions associated with an increased risk of breast cancer. Nat Rev Clin Oncol 2015;12(4):227-38.
Bissell MCS, Kerlikowske K, Sprague BL, et al. Breast cancer population attributable risk proportions associated with body mass index and breast density by race/ethnicity and menopausal status. Cancer Epidemiol Biomark Prev 2020;29(10):2048-56.
Pollán M, Ascunce N, Ederra M, et al. Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study. Breast Cancer Res BCR 2013;15(1):R9.
Ramón y Cajal T, Chirivella I, Miranda J, et al. Mammographic density and breast cancer in woman from high risk families. Breast Cancer Res BCR 2015;17(1):93.
Assi V, Warwick J, Cuzick J, Duffy SW. Clinical and epidemiological issues in mammographic density. Nat Rev Clin Oncol 2012;9(1):33-40.
Huo CW, Chew GL, Britt KL, et al. Mammographic density: a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat 2014;144(3):479-502.
Howell A, Anderson AS, Clarke RB, et al. Risk determination and prevention of breast cancer. Breast Cancer Res 2014;16(5):446.
Nichols HB, Schoemaker MJ, Cai J, et al. Breast cancer risk after recent childbirth: A pooled analysis of 15 prospective studies. Ann Intern Med 2019;170(1):22-30.
Fortner RT, Sisti J, Chai B, et al. Parity, breastfeeding and breast cancer risk by hormone receptor status and molecular phenotype: Results from the Nurses’ Health Studies. Breast Cancer Res 2019;21(1):40.
Lambertini M, Santoro L, del Mastro L, et al. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies. Cancer Treat Rev 2016;49:65-76.
World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report. Lactation and the risk of cancer; 2018. Disponible en: https://www.wcrf. org/wp-content/uploads/2021/02/Lactation.pdf
Islami F, Liu Y, Jemal A, et al. Breastfeeding and breast cancer risk by receptor status: A systematic review and meta-analysis. Ann Oncol 2015;26(12):2398-407.
Karlsson T, Johansson T, Höglund J, et al. Time-dependent effects of oral contraceptive use on breast, ovarian and endometrial cancers. Cancer Res 2021;81(4):1153-62.
Mørch LS, Skovlund CW, Hannaford PC, et al. Contemporary Hormonal Contraception and the Risk of Breast Cancer. N Engl J Med 2017;377(23):2228-39.
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347(9017):1713-27.
Burchardt NA, Eliassen AH, Shafrir AL, et al. Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses’ Health Study II: A prospective cohort study. Am J Obstet Gynecol 2022;226(6):821.e1-26.
Silva FR, Grande AJ, Lacerda Macedo AC, et al. Meta-analysis of breast cancer risk in levonorgestrel-releasing intrauterine system users. Clin Breast Cancer 2021;21(6):497-508. 36. Conz L, Mota BS, Bahamondes L, et al. Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis. Acta Obstet Gynecol Scand 2020;99(8):970-82.
Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women’s health initiative randomized clinical trials. JAMA 2020;324(4):369-80.
Beebeejaun Y, Athithan A, Copeland TP, et al. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: A systematic review and meta-analysis. Fertil Steril 2021;116(1):198-207.
Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol 2017;18(8):e457-71. 40. McTiernan A, Friedenreich CM, Katzmarzyk PT, et al; 2018 Physical Activity Guidelines Advisory Committee*. Physical activity in cancer prevention and survival: A systematic review. Med Sci Sports Exerc 2019;51(6):1252-61.
Pollán M, Casla-Barrio S, Alfaro J, Esteban C, et al. Exercise and cancer: A position statement from the Spanish Society of Medical Oncology. Clin Transl Oncol 2020;22(10):1710-29.
Macacu A, Autier P, Boniol M, Boyle P. Active and passive smoking and risk of breast cancer: a meta-analysis. Breast Cancer Res Treat 2015;154(2):213-24.
Gaudet MM, Carter BD, Brinton LA, et al. Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies. Int J Epidemiol 2017;46(3):881-93.
Ehrhardt MJ, Howell CR, Hale K, et al. Subsequent breast cancer in female chilhood cancer survivors in the St Jude Lifetime cohort Study (SJLIFE). J Clin Oncol 2019;37(19):1647-56.
Wild CP, Weiderpass E, Stewart BW, editors. World Cancer Report: Cancer Research for Cancer Prevention. International Agency for Research on Cancer; 2020. Disponible en: https:// publications.iarc.fr/586 46. Ronckers CM, Erdmann CA, Land CE. Radiation and breast cancer: A review of current evidence. Breast Cancer Res 2005;7(1):21-32.
International Agency for Research on Cancer (IARC). IARC Monographs on the identification of carcinogenic hazards to humans; last update in 2022. Disponible en: https://monographs. iarc.who.int/agents-classified-by-the-iarc/
International Agency for Research on Cancer (IARC). Night shift work: IARC monographs on the identification of carcinogenic hazards to humans 2020;124.
Wegrzyn LR, Tamimi RM, Rosner BA, et al. Rotating night-shift work and the risk of breast cancer in the Nurses’ Health Studies. Am J Epidemiol 2017;186(5):532-40.
Stevens RG, Brainard GC, Blask DE, Lockley SW, Motta ME. Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J Clin 2014;64(3):207-18.
Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA 2006;296(2):193-201.
Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer Causes Control 2002;13(8):741-51.
Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med 2016;375(8):794-8.
Keum N, Greenwood DC, Lee DH, et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst 2015;107(2):djv088.
Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004;111(5):762-71.
Iyengar NM, Arthur R, Manson JE, et al. Association of body fat and risk of breast cancer in postmenopausal women with normal body mass index: A secondary analysis of a randomized clinical trial and observational study. JAMA Oncol 2019;5(2):155-63.
Neuhouser ML, Aragaki AK, Prentice RL, et al. Overweight, obesity and postmenopausal invasive breast cancer risk: A secondary analysis of the women’s health initiative randomized clinical trials. JAMA Oncol 2015;1(5):611-21.
Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95(16):1218-26.
Nelson HD, Zakher B, Cantor A, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 2012;156(9):635-48.
Schoemaker MJ, Nichols HB, Wright LB, et al; Premenopausal Breast Cancer Collaborative Group. Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol 2018;4(11):e181771.
World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report. Diet, nutrition, physical activity and breast cancer; 2018. Disponible en: https://www.wcrf.org/sites/default/files/Breast-cancer-report.pdf
Assi N, Rinaldi S, Viallon V, et al. Mediation analysis of the alcohol- postmenopausal breast cancer relationship by sex hormones in the EPIC cohort. Int J Cancer 2020;146(3):759-68.
Schütze M, Boeing H, Pischon T, t al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ 2011;342:d1584.
Castelló A, Pollán M, Buijsse B, et al. GEICAM researchers. Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study. Br J Cancer 2014;111(7):1454-62.
López V, Fernández N, Ruiz Moreno E, et al. Epidemiología del cáncer de mama. En: Martín M. Manual Práctico de Oncología. Cáncer de Mama. 1.ª edición. Amazing Books;2021:15-39.